Market Watch List: Portola Pharmaceuticals (NASDAQ:PTLA), Opko Health (NYSE:OPK), Bellatrix Exploration (NYSE:BXE), Konami Corp. (NYSE:KNM), Steiner Leisure (NASDAQ:STNR)

Portola Pharmaceuticals (Nasdaq:PTLA) announced that the Independent Data Monitoring Committee (IDMC) recommended that the Phase 3 APEX (Acute Medically Ill VTE Prevention with Extended Duration Betrixaban) Study of betrixaban continue as planned without modification based on the successful completion of a pre-specified futility analysis. In making this recommendation, the IDMC evaluated preliminary efficacy trends and safety reports from the first half of the study. On Friday shares of Portola Pharmaceuticals, Inc. (NASDAQ:PTLA) closed at $30.83.

On February 2, Opko Health, Inc. (NYSE:OPK) said that it has submitted an investigational new drug (IND) application to the US Food and Drug Administration (FDA) seeking approval to conduct a Phase IIa trial of its long-acting version of coagulation Factor VIIa (Factor VIIa-CTP) to treat bleeding episodes in hemophilia A or B patients with inhibitors to Factor VIII or Factor IX.c. Opko Health, Inc. (NYSE:OPK) in last trading activity advanced 0.22% to close at $13.50. Company weekly performance is 11.29% while its quarterly performance stands at 61.10%. Opko Health, Inc. (NYSE:OPK) is -0.30% away from its 52 week high.

On February 4, Bellatrix Exploration Ltd. (NYSE:BXE) announced an updated 2015 net capital budget of up to $200 million, reduced from the previously announced $300 million. The revised capital budget is designed to preserve Bellatrix’s favorable financial position in the current commodity price environment. Bellatrix expects to access up to $85 million of joint venture capital in 2015, resulting in gross capital spending for the year of up to $285 million. Pursuant to its existing joint venture arrangements, Bellatrix may access up to $250 million of additional joint venture capital in 2016 and beyond. On last trading day Bellatrix Exploration Ltd. (NYSE:BXE) advanced 0.90% to close at $2.24. Its volatility for the week is 9.89% while volatility for the month is 9.26%. Bellatrix Exploration Ltd. (NYSE:BXE) monthly performance is -21.95%.

Konami Corp. (NYSE:KNM)’s net income rose to Yen6,909m in the nine months to the end of December – 36.7% up on last time. Net revenues were virtually flat at Yen155,889m but operating income rose by 31.7% to Yen9,734m. Konami Corp. (NYSE:KNM) institutional ownership stands at 0.10%. In last trading activity company’s stock closed at $19.79.

TheStreet cut shares of Steiner Leisure Ltd (NASDAQ:STNR) from a buy rating to a hold rating in a research note issued to investors on Friday. On last trading day Steiner Leisure Ltd. (NASDAQ:STNR) advanced 0.13% to close at $46.07. Its volatility for the week is 2.73% while volatility for the month is 2.95%. STNR’s sales growth for past 5 years was 9.60% and its EPS growth for past 5 years was 2.40%. Steiner Leisure Ltd. (NASDAQ:STNR) monthly performance is 3.97%.

Leave a Reply

Your email address will not be published. Required fields are marked *

*